Sai Life Sciences is a full-service CRO-CDMO driven by a vision to support the launch of 25 new medicines by 2025. It works with innovator pharma and biotech companies globally, accelerating the discovery, development, and manufacture of complex small molecules. As a pure-play CRO-CDMO, Sai Life Sciences has served diverse NCE development programs, consistently delivering value based on its quality and responsiveness. Today, it works with 7 of the top 10 large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments.
Shared 7 months ago
202 views
Shared 3 years ago
7.6K views
Shared 3 years ago
1.5K views
Shared 3 years ago
3.7K views
Shared 3 years ago
2.3K views
Shared 3 years ago
661 views
Shared 3 years ago
1.3K views
Shared 3 years ago
1K views
Shared 3 years ago
2K views
Shared 3 years ago
749 views
Shared 3 years ago
1.2K views
Shared 3 years ago
1.6K views
Shared 3 years ago
954 views
Shared 3 years ago
277 views
Shared 3 years ago
576 views
Shared 3 years ago
194 views
Shared 3 years ago
321 views
Shared 3 years ago
1.3K views
Shared 3 years ago
597 views
Shared 4 years ago
812 views
Shared 4 years ago
138 views
Shared 4 years ago
266 views
Shared 4 years ago
145 views
Shared 4 years ago
3.2K views
Shared 4 years ago
2.4K views
Shared 4 years ago
1.4K views
Shared 4 years ago
407 views
Shared 4 years ago
505 views
Shared 4 years ago
409 views
Shared 5 years ago
1.8K views
Shared 5 years ago
189 views
Shared 5 years ago
559 views
Sai Life Sciences' Process R&D Centre at Manchester delivers better value to customers' NCE programs
Shared 5 years ago
2.4K views
Shared 5 years ago
588 views
Shared 5 years ago
13K views
Shared 5 years ago
1K views
Shared 5 years ago
9.9K views
